Clinical Trials Logo

Metastasis Skin clinical trials

View clinical trials related to Metastasis Skin.

Filter by:
  • None
  • Page 1

NCT ID: NCT03972046 Withdrawn - Melanoma (Skin) Clinical Trials

Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma

Start date: June 24, 2019
Phase: Phase 2
Study type: Interventional

This study will investigate whether the use of talimogene laherparepvec (T-VEC) in combination with BRAF/MEK inhibitor will result in durable regional and distant recurrence free survival in the neoadjuvant setting for treatment of advanced nodal BRAF mutant melanoma.